• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

X 连锁肌张力障碍-帕金森病中 SVA 反转录转座子引起的转录改变。

Transcriptional Alterations in X-Linked Dystonia-Parkinsonism Caused by the SVA Retrotransposon.

机构信息

Institute of Neurogenetics, University of Lübeck, 23538 Lübeck, Germany.

Institute of Human Genetics, University of Lübeck, 23538 Lübeck, Germany.

出版信息

Int J Mol Sci. 2022 Feb 17;23(4):2231. doi: 10.3390/ijms23042231.

DOI:10.3390/ijms23042231
PMID:35216353
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8875906/
Abstract

X-linked dystonia-parkinsonism (XDP) is a severe neurodegenerative disorder that manifests as adult-onset dystonia combined with parkinsonism. A SINE-VNTR-Alu (SVA) retrotransposon inserted in an intron of the gene reduces its expression and alters splicing in XDP patient-derived cells. As a consequence, increased levels of the intron retention transcript can be found in XDP cells as compared to healthy controls. Here, we investigate the sequence of the deep intronic region included in this transcript and show that it is also present in cells from healthy individuals, albeit in lower amounts than in XDP cells, and that it undergoes degradation by nonsense-mediated mRNA decay. Furthermore, we investigate epigenetic marks (e.g., DNA methylation and histone modifications) present in this intronic region and the spanning sequence. Finally, we show that the SVA evinces regulatory potential, as demonstrated by its ability to repress the promoter in vitro. Our results enable a better understanding of the disease mechanisms underlying XDP and transcriptional alterations caused by SVA retrotransposons.

摘要

X 连锁型肌张力障碍-帕金森病(XDP)是一种严重的神经退行性疾病,表现为成年起病的肌张力障碍合并帕金森病。一个插入 基因内含子中的短散在重复元件-可变数量串联重复(SINE-VNTR-Alu,SVA)反转录转座子会降低其表达并改变 XDP 患者来源细胞中的剪接。因此,与健康对照组相比,XDP 细胞中可以发现 内含子保留转录本的水平增加。在这里,我们研究了包含在该转录本中的深内含子区域的序列,并表明它也存在于来自健康个体的细胞中,尽管其丰度低于 XDP 细胞,并且它通过无意义介导的 mRNA 降解进行降解。此外,我们研究了该内含子区域和跨越序列中存在的表观遗传标记(例如,DNA 甲基化和组蛋白修饰)。最后,我们表明 SVA 具有调节潜能,这表现在其能够在体外抑制 启动子。我们的研究结果有助于更好地理解 XDP 的疾病机制以及 SVA 反转座子引起的转录改变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fce0/8875906/e1f15f3b0cc8/ijms-23-02231-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fce0/8875906/fd235cd478ee/ijms-23-02231-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fce0/8875906/4eab2991075c/ijms-23-02231-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fce0/8875906/d8e11330c843/ijms-23-02231-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fce0/8875906/e1f15f3b0cc8/ijms-23-02231-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fce0/8875906/fd235cd478ee/ijms-23-02231-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fce0/8875906/4eab2991075c/ijms-23-02231-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fce0/8875906/d8e11330c843/ijms-23-02231-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fce0/8875906/e1f15f3b0cc8/ijms-23-02231-g004.jpg

相似文献

1
Transcriptional Alterations in X-Linked Dystonia-Parkinsonism Caused by the SVA Retrotransposon.X 连锁肌张力障碍-帕金森病中 SVA 反转录转座子引起的转录改变。
Int J Mol Sci. 2022 Feb 17;23(4):2231. doi: 10.3390/ijms23042231.
2
Disease onset in X-linked dystonia-parkinsonism correlates with expansion of a hexameric repeat within an SVA retrotransposon in .X 连锁型肌张力障碍-帕金森病的发病与 SVA 反转录转座子内六聚体重复的扩展相关。
Proc Natl Acad Sci U S A. 2017 Dec 19;114(51):E11020-E11028. doi: 10.1073/pnas.1712526114. Epub 2017 Dec 11.
3
SVA insertion in X-linked Dystonia Parkinsonism alters histone H3 acetylation associated with TAF1 gene.X 连锁肌张力障碍帕金森病中的 SVA 插入改变了与 TAF1 基因相关的组蛋白 H3 乙酰化。
PLoS One. 2020 Dec 14;15(12):e0243655. doi: 10.1371/journal.pone.0243655. eCollection 2020.
4
Dissecting the Causal Mechanism of X-Linked Dystonia-Parkinsonism by Integrating Genome and Transcriptome Assembly.通过整合基因组和转录组组装来剖析 X 连锁型肌张力障碍-帕金森病的因果机制。
Cell. 2018 Feb 22;172(5):897-909.e21. doi: 10.1016/j.cell.2018.02.011.
5
Decreased N-TAF1 expression in X-linked dystonia-parkinsonism patient-specific neural stem cells.X连锁肌张力障碍-帕金森综合征患者特异性神经干细胞中N-TAF1表达降低。
Dis Model Mech. 2016 Apr;9(4):451-62. doi: 10.1242/dmm.022590. Epub 2016 Jan 14.
6
ZNF91 is an endogenous repressor of the molecular phenotype associated with X-linked dystonia-parkinsonism (XDP).ZNF91 是与 X 连锁肌张力障碍-帕金森病(XDP)相关分子表型的内源性抑制物。
Proc Natl Acad Sci U S A. 2024 Aug 13;121(33):e2401217121. doi: 10.1073/pnas.2401217121. Epub 2024 Aug 5.
7
Elucidating Hexanucleotide Repeat Number and Methylation within the X-Linked Dystonia-Parkinsonism (XDP)-Related SVA Retrotransposon in with Nanopore Sequencing.利用纳米孔测序阐明 X 连锁肌张力障碍-帕金森病(XDP)相关 SVA 反转录转座子中的六核苷酸重复数和甲基化。
Genes (Basel). 2022 Jan 11;13(1):126. doi: 10.3390/genes13010126.
8
The Effect of Glucocorticoids on Gene Transcription in X-linked Dystonia Parkinsonism.糖皮质激素对 X 连锁肌张力障碍帕金森病基因转录的影响。
J ASEAN Fed Endocr Soc. 2023;38(1):23-30. doi: 10.15605/jafes.037.S6. Epub 2022 Aug 7.
9
A hexanucleotide repeat modifies expressivity of X-linked dystonia parkinsonism.六核苷酸重复序列改变了 X 连锁型肌张力障碍帕金森病的表现度。
Ann Neurol. 2019 Jun;85(6):812-822. doi: 10.1002/ana.25488. Epub 2019 May 3.
10
Mini-heterochromatin domains constrain the cis-regulatory impact of SVA transposons in human brain development and disease.小型异染色质结构域限制 SVA 转座子在人类大脑发育和疾病中的顺式调控作用。
Nat Struct Mol Biol. 2024 Oct;31(10):1543-1556. doi: 10.1038/s41594-024-01320-8. Epub 2024 Jun 4.

引用本文的文献

1
Retrotransposon: an insight into neurological disorders from perspectives of neurodevelopment and aging.逆转录转座子:从神经发育和衰老角度洞察神经疾病
Transl Neurodegener. 2025 Mar 25;14(1):14. doi: 10.1186/s40035-025-00471-y.
2
Triplex H-DNA structure: the long and winding road from the discovery to its role in human disease.三链体H-DNA结构:从发现到其在人类疾病中作用的漫长曲折之路。
NAR Mol Med. 2024 Dec 5;1(4):ugae024. doi: 10.1093/narmme/ugae024. eCollection 2024 Oct.
3
The roles of TAF1 in neuroscience and beyond.TAF1在神经科学及其他领域的作用。

本文引用的文献

1
Elucidating Hexanucleotide Repeat Number and Methylation within the X-Linked Dystonia-Parkinsonism (XDP)-Related SVA Retrotransposon in with Nanopore Sequencing.利用纳米孔测序阐明 X 连锁肌张力障碍-帕金森病(XDP)相关 SVA 反转录转座子中的六核苷酸重复数和甲基化。
Genes (Basel). 2022 Jan 11;13(1):126. doi: 10.3390/genes13010126.
2
Perspective in Alternative Splicing Coupled to Nonsense-Mediated mRNA Decay.可变剪接与无义介导的 mRNA 降解相偶联的观点。
Int J Mol Sci. 2020 Dec 10;21(24):9424. doi: 10.3390/ijms21249424.
3
SVA insertion in X-linked Dystonia Parkinsonism alters histone H3 acetylation associated with TAF1 gene.
R Soc Open Sci. 2024 Sep 25;11(9):240790. doi: 10.1098/rsos.240790. eCollection 2024 Sep.
4
Neuroenergetic Changes in Patients with X-Linked Dystonia-Parkinsonism and Female Carriers.X 连锁肌张力障碍-帕金森病患者和女性携带者的神经能量变化。
Mov Disord Clin Pract. 2024 May;11(5):550-555. doi: 10.1002/mdc3.14001. Epub 2024 Feb 25.
5
Proteomic analysis of X-linked dystonia parkinsonism disease striatal neurons reveals altered RNA metabolism and splicing.X 连锁型肌张力障碍帕金森病纹状体神经元的蛋白质组学分析显示 RNA 代谢和剪接发生改变。
Neurobiol Dis. 2024 Jan;190:106367. doi: 10.1016/j.nbd.2023.106367. Epub 2023 Nov 30.
6
CRISPR deletion of a SINE-VNTR- (SVA_67) retrotransposon demonstrates its ability to differentially modulate gene expression at the locus.CRISPR对一个短散在核元件-可变数目串联重复序列-(SVA_67)反转录转座子的缺失证明了其在该位点差异调节基因表达的能力。
Front Neurol. 2023 Sep 29;14:1273036. doi: 10.3389/fneur.2023.1273036. eCollection 2023.
7
Transcriptional Regulation and Its Misregulation in Human Diseases.转录调控及其在人类疾病中的异常调控。
Int J Mol Sci. 2023 May 12;24(10):8640. doi: 10.3390/ijms24108640.
8
The Effect of Glucocorticoids on Gene Transcription in X-linked Dystonia Parkinsonism.糖皮质激素对 X 连锁肌张力障碍帕金森病基因转录的影响。
J ASEAN Fed Endocr Soc. 2023;38(1):23-30. doi: 10.15605/jafes.037.S6. Epub 2022 Aug 7.
X 连锁肌张力障碍帕金森病中的 SVA 插入改变了与 TAF1 基因相关的组蛋白 H3 乙酰化。
PLoS One. 2020 Dec 14;15(12):e0243655. doi: 10.1371/journal.pone.0243655. eCollection 2020.
4
TAF1 Transcripts and Neurofilament Light Chain as Biomarkers for X-linked Dystonia-Parkinsonism.TAF1 转录本和神经丝轻链作为 X 连锁肌张力障碍-帕金森病的生物标志物。
Mov Disord. 2021 Jan;36(1):206-215. doi: 10.1002/mds.28305. Epub 2020 Sep 25.
5
Expanding Data Collection for the MDSGene Database: X-linked Dystonia-Parkinsonism as Use Case Example.扩充 MDSGene 数据库的数据收集:以 X 连锁型肌张力障碍-帕金森病为例。
Mov Disord. 2020 Nov;35(11):1933-1938. doi: 10.1002/mds.28289. Epub 2020 Sep 19.
6
DNA Methylation as a Potential Molecular Mechanism in X-linked Dystonia-Parkinsonism.DNA 甲基化作为 X 连锁型肌张力障碍-帕金森病的潜在分子机制。
Mov Disord. 2020 Dec;35(12):2220-2229. doi: 10.1002/mds.28239. Epub 2020 Sep 10.
7
Neuroinflammation and histone H3 citrullination are increased in X-linked Dystonia Parkinsonism post-mortem prefrontal cortex.X 连锁型肌张力障碍帕金森综合征尸检前额皮质中神经炎症和组蛋白 H3 瓜氨酸化增加。
Neurobiol Dis. 2020 Oct;144:105032. doi: 10.1016/j.nbd.2020.105032. Epub 2020 Jul 31.
8
Methods for ChIP-seq analysis: A practical workflow and advanced applications.ChIP-seq 分析方法:实用工作流程和高级应用。
Methods. 2021 Mar;187:44-53. doi: 10.1016/j.ymeth.2020.03.005. Epub 2020 Mar 30.
9
H3K36me3, message from chromatin to DNA damage repair.H3K36me3:从染色质到DNA损伤修复的信号
Cell Biosci. 2020 Jan 31;10:9. doi: 10.1186/s13578-020-0374-z. eCollection 2020.
10
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease.患者定制型寡核苷酸疗法治疗罕见遗传病。
N Engl J Med. 2019 Oct 24;381(17):1644-1652. doi: 10.1056/NEJMoa1813279. Epub 2019 Oct 9.